4 completed, 1 unknown, 1 withdrawn. 3 Phase 3, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Withdrawn 1 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow naftopidil: new trials by email Literature Review of naftopidil trials Research Report on naftopidil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Naftopidil for the Double-J Stent Discomfort Naftopidil, Placebo for Naftopidil, Standard treatment - Disorder of Urinary Stent | Phase 3 | Completed | Seoul National University Hospital | 100 | 2014-05-01 | 2015-12-10 |
| Medical Expulsive Therapy for Ureter Stone Using Naftopidil Naftopidil 75mg, Placebo for Naftopidil, Standard treatment - Ureter Stones | Phase 3 | Completed | Seoul National University Hospital | 150 | 2014-05-01 | 2015-12-10 |
| Naftopidil 75mg for Improving Clearance of Urinary Stones naftopidil 75mg - Kidney Calculi, Ureter Calculi | Phase 4 | Unknown | Samsung Medical Center | 130 | 2014-02-01 | 2013-12-13 |
| Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Naftopidil - Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia | Phase 4 | Completed | Dong-A Pharmaceutical Co., Ltd. | 411 | 2011-12-01 | 2013-08-14 |
| Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS Naftopidil, Tamsulosin - Hyperplasia | Phase 3 | Withdrawn | Apsen Farmaceutica S.A. | 2011-01-01 | 2026-09-09 | |
| The Safety/Tolerability and Pharmacokinetics (PKs) of Naftopidil in Korean Healthy Male Volunteers Naftopidil - Healthy | Phase 1 | Completed | Dong-A ST Co., Ltd. | 16 | 2009-09-01 | 2014-10-01 |
Hyperplasia (1) · Kidney Calculi (1) · Prostatic Hyperplasia (1)
Seoul National University Hospital (2) · Apsen Farmaceutica S.A. (1) · Dong-A Pharmaceutical Co., Ltd. (1) · Dong-A ST Co., Ltd. (1) · Samsung Medical Center (1)
South Korea (5) · Brazil (1)
Chang Wook Jeong, M.D., Ph.D. (2) · Dae Yul Yang Yang, MD, PhD (1) · Deok Hyun Han, M.D. (1) · Du-Geon Moon, MD, PhD (1) · Jae-Seok Hyun, Md, PhD (1) · Ji- Kan Ryu, MD, PhD (1) · Jong Kwan Park, MD, PhD (1) · Ki-Hak Moon, Md, PhD (1) · Kweon-Sik Min, MD, PhD (1) · Kyung-Sang Yu, M.D.,Ph.D. (1) · Nam-Cheol Park, MD, PhD (1) · Sae-Woong Kim, MD.PhD (1) · Soo-Woong Kim, Md, PhD (1) · Sung-Won Lee, MD, PhD (1) · Tai-Young Ahn, Md, PhD (1)